Accessibility settings

Published on in Vol 6 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/69800, first published .
Close-up of a hand typing on a laptop keyboard, focusing on fingertips and keys.

Harnessing AI and Quantum Computing for Revolutionizing Drug Discovery and Approval Processes: Case Example for Collagen Toxicity

Harnessing AI and Quantum Computing for Revolutionizing Drug Discovery and Approval Processes: Case Example for Collagen Toxicity

Authors of this article:

David Melvin Braga1 Author Orcid Image ;   Bharat Rawal2 Author Orcid Image

Journals

  1. Das U. Transforming Precision Medicine through Generative AI: Advanced Architectures and Tailored Therapeutic Design for Patient‐Specific Drug Discovery. ChemistrySelect 2025;10(36) View
  2. Matarèse B. Quantum and Artificial Intelligence in Drugs and Pharmaceutics. BioChem 2026;6(1):2 View
  3. Sargolzaei M, Nikoofard H. AI-driven quantum chemical exploration of multi-target synthetic opioid analogs for enhanced therapeutic profiles. Journal of Computer-Aided Molecular Design 2026;40(1) View
  4. Devadas R, T S. Quantum technologies in clinical medicine: a systematic cross-domain synthesis and translational readiness taxonomy. Journal of King Saud University Computer and Information Sciences 2026;38(7) View

Books/Policy Documents

  1. Islam Khan M, Sojib N, Karim M, Roosan D. Quantum Informatics for Novel Therapeutics. View
  2. Takawira B. Architecting Strategic Business Transformation Through Data-Driven Systems. View
  3. Patel T. AI, Nanobiotechnology, and the Future of Precision Antibiotics. View
  4. Wangsa K, Karim S, Sandu R, Singh P. Proceedings of 11th International Congress on Information and Communication Technology. View